IDH2 R172 Mutations Define a Unique Subgroup of Patients in Angioimmunoblastic T-Cell Lymphoma
Chao Wang(Shandong University), Wing C. Chan(Ontario Institute for Cancer Research), Karen Dybkær(Aalborg University Hospital), Dennis D. Weisenburger(University of Nebraska Medical Center), Timothy W. McKeithan(Palmetto Hematology Oncology), Louis M. Staudt(National Cancer Institute), Randy D. Gascoyne(BC Cancer Agency), Andrew Cannon(University of Nebraska Medical Center), Lynette M. Smith(University of Nebraska Medical Center), Timothy C. Greiner(University of Nebraska Medical Center), Andreas Rosenwald, Christian Steidl(University of British Columbia), Javeed Iqbal(University of Nebraska Medical Center), Eleanor G. Rogan(University of Nebraska Medical Center), Joseph Rohr, German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Julie M. Vose(University of Nebraska Medical Center), Alyssa Bouska(University of Nebraska Medical Center), Françoise Berger(Hôpital Lyon Sud), Masao Seto(Aichi Cancer Center), Shigeo Nakamura(University of the Ryukyus), Kai Fu(Soochow University), Weiwei Zhang(Capital Normal University), Bei Jiang(Hong Kong Polytechnic University)
Cited by 4
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
|Cell|2008|2.6k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k